<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00644345</url>
  </required_header>
  <id_info>
    <org_study_id>38-08</org_study_id>
    <nct_id>NCT00644345</nct_id>
  </id_info>
  <brief_title>T-Wave Alternans (TWA) Reproducibility in CAD Patients</brief_title>
  <official_title>Reproducibility of T Wave Alternans Testing in Patients With Ischemic Heart Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Microvolt T-Wave Alternans (MTWA) is a relatively new non-invasive method for identifying&#xD;
      patients at increased risk of sudden death from ventricular arrhythmias. MTWA can be measured&#xD;
      during a routine exercise test, during pharmacologic stress or during cardiac pacing. Its&#xD;
      clinical performance compares favorably with that of other non-invasive risk stratifiers and&#xD;
      invasive electophysiologic studies. The purpose of the present study is to define the&#xD;
      reproducibility of MTWA testing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be performed in the Cardiac Rehabilitation Center at Assaf Harofeh Medical&#xD;
      Center. Patients with coronary artery disease will be eligible to enroll.&#xD;
&#xD;
      Patient will undergo an exercise test on a stationary bicycle. TWA will be measured at heart&#xD;
      rate of 105 and 115 BPM. The test will be repeated one week later in the same fashion. The&#xD;
      patient will continue follow-up in the rehabilitation center as dictated by the&#xD;
      rehabilitation program. Patients will be kept on their regular medications and there will be&#xD;
      no change of the medications from the first TWA measurement to the second.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2008</start_date>
  <completion_date type="Anticipated">May 2009</completion_date>
  <primary_completion_date type="Anticipated">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reproducibility of TWA test results</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventricular arrhythmias during exercise</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Coronary Artery Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary artery disease enrolled in a cardiac rehabilitation program.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients enrolled in the cardiac rehabilitation center program&#xD;
&#xD;
          2. Patients with CAD&#xD;
&#xD;
          3. Age &gt;18 and &lt; 80 YO&#xD;
&#xD;
          4. Patients with a pacemaker or defibrillator with normal AV conduction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with chronic AF&#xD;
&#xD;
          2. Patients with multiple APB's or PVC's&#xD;
&#xD;
          3. Patients who are unable to increase their heart rate to 115 BPM and don't have a&#xD;
             pacemaker.&#xD;
&#xD;
          4. Patients who are unable to exercise on a bicycle.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Therese Fuchs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assaf-Harofeh Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Therese Fuchs, MD</last_name>
    <phone>972-8-977-9735</phone>
    <email>fuchst@asaf.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isaac Zysman, MD</last_name>
    <phone>972-8-977-9735</phone>
    <email>zysmanI@asaf.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assaf Harofeh Medical Center</name>
      <address>
        <city>Zrifin</city>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Therese Fuchs, MD</last_name>
      <phone>972-8-977-9735</phone>
      <email>fuchst@asaf.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Isaac Zysman, MD</last_name>
      <phone>972-8-977-9735</phone>
      <email>zysmanI@asaf.health.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>Therese Fuchs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <study_first_submitted>March 23, 2008</study_first_submitted>
  <study_first_submitted_qc>March 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2008</study_first_posted>
  <last_update_submitted>March 25, 2008</last_update_submitted>
  <last_update_submitted_qc>March 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2008</last_update_posted>
  <responsible_party>
    <name_title>Therese Fuchs, MD</name_title>
    <organization>Assaf Harofeh Medical Center</organization>
  </responsible_party>
  <keyword>Microvolt T wave alternans</keyword>
  <keyword>reproducibility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

